# Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)

> **NCT01082393** · PHASE4 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 14 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** topical tacrolimus treatment
- **DRUG:** topical pimecrolimus treatment
- **DRUG:** local mometasone furoate treatment
- **DRUG:** cold cream

## Key facts

- **NCT ID:** NCT01082393
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-16
- **Primary completion:** 2015-09-15
- **Final completion:** 2015-12-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082393, "Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01082393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*